Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1525 of 1958 entries
View as:

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Phase: N/A Priority: Normal
NCT ID: NCT00191750 Org: User:
Start: 07/31/04 End: 09/30/06 Due: 09/30/07

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03603704 Org: User:
Start: 08/17/18 End: 05/27/19 Due: 05/27/20

Study of Food on Evacetrapib (LY2484595) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01810432 Org: User:
Start: 03/31/13 End: 06/30/13 Due: 06/30/14

A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02443337 Org: User:
Start: 07/31/15 End: 09/30/17 Due: 09/30/18

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

Phase: N/A Priority: Normal
NCT ID: NCT01709110 Org: User:
Start: 10/31/12 End: 07/31/16 Due: 07/31/17

Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00383331 Org: User:
Start: 02/28/07 End: 01/31/08 Due: 01/31/09

A Dose-Escalation Study in Participants With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01524224 Org: User:
Start: 01/31/08 End: 01/31/16 Due: 01/31/17

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Phase: N/A Priority: Normal
NCT ID: NCT00191399 Org: User:
Start: 05/31/04 End: 03/31/06 Due: 03/31/07

Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

Phase: N/A Priority: Normal
NCT ID: NCT00190736 Org: User:
Start: 09/30/04 End: 09/30/06 Due: 09/30/07

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

Phase: N/A Priority: Normal
NCT ID: NCT04146363 Org: User:
Start: 09/24/19 End: 05/03/22 Due: 05/03/23

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00380692 Org: User:
Start: 10/31/06 End: 10/31/08 Due: 10/31/09

A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01825889 Org: User:
Start: 04/30/13 End: 10/31/13 Due: 10/31/14

A Study of Lasmiditan on the Heart in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03465436 Org: User:
Start: 09/16/11 End: 12/20/11 Due: 12/20/12

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Phase: N/A Priority: Normal
NCT ID: NCT05369403 Org: User:
Start: 12/19/22 End: 02/05/25 Due: 02/05/26

A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04957914 Org: User:
Start: 07/14/21 End: 10/17/22 Due: 10/17/23

A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01005680 Org: User:
Start: 11/30/09 End: 11/30/12 Due: 11/30/13

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01198002 Org: User:
Start: 12/31/10 End: 01/31/14 Due: 01/31/15

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04701658 Org: User:
Start: 02/01/21 End: 06/22/21 Due: 06/22/22

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01215955 Org: User:
Start: 12/31/10 End: 01/31/13 Due: 01/31/14

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

Phase: N/A Priority: Normal
NCT ID: NCT05959096 Org: User:
Start: 07/18/23 End: 07/25/24 Due: 07/25/25

A Study of LY3214996 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04033341 Org: User:
Start: 08/01/19 End: 09/09/19 Due: 09/09/20

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Phase: N/A Priority: Normal
NCT ID: NCT00266643 Org: User:
Start: 12/31/05 End: 04/30/07 Due: 04/30/08

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00381732 Org: User:
Start: 10/31/03 End: 06/30/06 Due: 06/30/07

Study of Prasugrel in Korean Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01591317 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

A Study in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01421459 Org: User:
Start: 09/30/11 End: 09/30/12 Due: 09/30/13